Our Latest Thinking

We are constantly scanning the health care market for new and interesting developments; then we write about them here. Check out our latest thinking.

Medicaid

Opportunities in an Evolving Market: 2019 Health Care & Life Sciences Investment Outlook

January 8th, 2019

The analysis of the 2019 KPMG/Leavitt Partners Health Care and Life Sciences Investment Survey sheds light on how key disruptors, prevailing market trends and evolving policies will impact the 2019 investment arena. We asked investment professionals to answer questions about several health care subsectors in which they have expertise. Upon examining the data, we divided […]

Read More >

Trump Administration Looks to Take Medicaid Outside The Doctor’s Office

December 6th, 2018

The article discusses the Trump Administration and its look to take Medicaid outside the doctor’s office.

Read More >

Voluntary code of conduct developed by more than 60 industry stakeholders can help facilitate health data exchange with entities not covered by HIPAA

November 27th, 2018

The CARIN Alliance, a multi-sector group of health care and other stakeholders, has developed a voluntary code of conduct for entities not covered by HIPAA, such as third-party applications, when handling health care data accessed via application programming interfaces (APIs).

Read More >

Implications of the 2018 Midterm Elections

November 16th, 2018

Health care was a central issue in this year’s midterm elections. In the days after the election, many have speculated on what the results mean for U.S. health care policy. Since the Republicans maintained control of the Senate, while the Democrats took control of the House, some see the next two years as a time […]

Read More >

Medicaid Closed Drug Formularies: A Closed Door or a Path Forward?

October 2nd, 2018

As we noted in July, CMS declined Massachusetts’ Medicaid 1115 demonstration request to establish a closed formulary.  The proposed program would have given Massachusetts the ability to exclude certain FDA-approved drugs from coverage and thereby given the state additional leverage in negotiating rebates.  The state and drug manufacturers would have otherwise continued to be subject […]

Read More >

Leavitt Partners Selected to Participate in the Massachusetts Delivery System Reform Incentive Payment Technical Assistance Marketplace

September 21st, 2018

Salt Lake City, September 21, 2018 –Today, Leavitt Partners announced that the firm has been selected to participate in the Massachusetts Delivery System Reform Incentive Payment (DSRIP) Technical Assistance (TA) Program and TA Marketplace. The TA Marketplace is part of a broader initiative of  MassHealth, the Commonwealth of Massachusetts’ Medicaid and Children’s Health Insurance Program, […]

Read More >

Medicaid Expansion Finds Grass-Roots Support in Conservative Utah

September 11th, 2018

Andrew Croshaw provided commentary on Utah’s Medicaid expansion ballot initiative for a New York Times article entitled “Medicaid Expansion Finds Grass-Roots Support in Conservative Utah.” “Polls suggest that the ballot measure is likely to pass,” said Andrew Croshaw, the chief executive of Leavitt Partners, a health care consulting firm founded by former Gov. Michael O. […]

Read More >

Medicaid ACOs on the Rise, but Differ Greatly Amongst States

August 20th, 2018

A Provider article entitled “Medicaid ACOs on the Rise, but Differ Greatly Amongst States” presents key findings and provides a brief overview of the four different types of Medicaid ACOs as described in the Leavitt Partners “Medicaid ACOs: Understanding Different State Approaches” white paper.

Read More >